Martine A. Rothblatt - Aug 26, 2024 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Chairperson & CEO, Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Aug 26, 2024
Transactions value $
-$58,890
Form type
4
Date filed
8/28/2024, 04:30 PM
Previous filing
Aug 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $34.8K +269 +206.92% $129.49 399 Aug 26, 2024 Direct F1
transaction UTHR Common Stock Sale -$9.72K -28 -7.02% $347.27 371 Aug 26, 2024 Direct F1, F2
transaction UTHR Common Stock Sale -$68.2K -196 -52.83% $348.20 175 Aug 26, 2024 Direct F1, F3
transaction UTHR Common Stock Sale -$7.68K -22 -12.57% $349.21 153 Aug 26, 2024 Direct F1
transaction UTHR Common Stock Sale -$8.07K -23 -15.03% $350.86 130 Aug 26, 2024 Direct F1
holding UTHR Common Stock 166 Aug 26, 2024 By Spouse
holding UTHR Common Stock 246K Aug 26, 2024 By Trust F4
holding UTHR Common Stock 28.2K Aug 26, 2024 By Trust F5
holding UTHR Common Stock 325K Aug 26, 2024 By Trust F6
holding UTHR Common Stock 45.6K Aug 26, 2024 By Trust F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Options Options Exercise $0 -269 -100% $0.00 0 Aug 26, 2024 Common Stock 269 $129.49 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $349.78 to $347.715. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 This transaction was executed in multiple trades at prices ranging from $347.86 to $348.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
F5 Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
F6 Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
F7 Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
F8 Reflects the correction of a clerical error in the reporting person's Form 4 filed on August 21, 2024, which error caused the reporting person's stock option holding to be overreported by 3600 shares in such Form 4 and in the reporting person's subsequently filed Form 4.